According to the World Health Organization, cardiovascular disease (CVD) is the leading cause of death and disability in the world today. With more than 17.5 million deaths annually from CVD, finding effective treatment options is critical. Northwestern University Feinberg School of Medicine scientists are hard at work to find innovative new therapies to treat and prevent CVD.
Cholesterol levels in U.S. youth have improved from 1999 to 2016, but only half of children and adolescents are in the ideal range, according to a new study published in JAMA.
Death rates due to heart failure are now increasing, and this increase is most prominent among younger adults under 65, according to a new study.
A quality improvement program significantly increased the proportion of patients who were appropriately prescribed blood thinners for atrial fibrillation at hospital discharge.
Northwestern faculty translate cardiovascular discoveries into clinical guidelines for the nation.
Northwestern Medicine investigators are developing better treatments and care for patients with the most prevalent of diseases. Read the feature in Northwestern Medicine magazine.
Women who’ve previously experienced a heart attack are twice as likely to develop mental stress-induced ischemia compared to men with a similar history, according to a recent study.
A new study shows a patient’s overall heart disease risk assessment can better determine blood pressure treatment, as opposed to examining blood pressure levels alone.
A new study debunks the “obesity paradox,” a counterintuitive finding that people with cardiovascular disease live longer if they are overweight or obese.
At Keep Your Heart Healthy events, Feinberg medical students provide cardiovascular disease risk assessment and prevention counseling to underserved communities.